NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/16/2024
Back to search
Official data from USPTO
GEM 21 NEUROPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GEM 21 NEUROPLEX
ST13
US500000087584355Class
1
Filing
87584355
Registration
5473957
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/16/2024
Trademark type
Word
Nice classes
1
Filing date
08/25/2017
Registration date
05/22/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2024
Last transaction
08/16/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
02/22/2010
First use in commerce
02/24/2010
Drawing code
4
Owner type
03
Owner location
WEST SACRAMENTO, CA
Examiner
RYDLAND,STEPHANIE DIANA
Current location
Historical data usage
Holders and representatives
Holders
GEMINI BIOPRODUCTS HOLDING, INC.
GEMINI BIOPRODUCTS, INC.
Representatives
Kevin S. Costanza Seed IP Law Group LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Media reagents for clinical or medical laboratory use and research use
Publications
History of USPTO decisions and trademark events.
24 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/16/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/16/2024
E815
TEAS SECTION 8 & 15 RECEIVED
01/31/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/22/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/21/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/26/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/13/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/22/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2018
PUBO
PUBLISHED FOR OPPOSITION
03/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2018
ALIE
ASSIGNED TO LIE
01/26/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/16/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
12/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/11/2017
DOCK
ASSIGNED TO EXAMINER
11/30/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2017
Continuous trademark protection
Get notified about every new filing that threatens GEM 21 NEUROPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.